FindTrial
Sign In

A study on oral sucrose of analgesia in premature infants undergoing heel lance

A Study on the optimal dose of oral sucrose of analgesia in premature infants undergoing heel lance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054628
Enrollment
Unknown
Registered
2021-12-22
Start date
2016-12-01
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain caused by heel lance

Interventions

Experimental group2:24% sucrose solution 0.3ml
Experimental group3:24% sucrose solution 0.5ml
Control group:None
Experimental group1:24% sucrose solution 0.1ml

Sponsors

Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 32 weeks = 1500g.

Exclusion criteria

Exclusion criteria: 1. Apgar score <6 at 5 minutes after birth; 2. Have neurological symptoms or signs; 3. Give oxygen or use a ventilator; 4. Analgesics or sedatives have been used within 48 hours; 5. Prenatal or intrapartum medication for mothers (magnesium sulfate, sedatives, analgesics); 6. Congenital heart disease or deformed child; 7. Analgesia identified by general standards; 8. Hyperglycemia; 9. Necrotizing colitis.

Design outcomes

Primary

MeasureTime frame
Pain response and score;Side effects;—

Countries

China

Contacts

Public ContactCheng Jing

Affiliated Hospital of Nantong University

chengjing@ntu.edu.cn+86 13912298527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026